Pharma Journalist - Page 693 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Banyan Biomarkers attained FDA’s De Novo request for Banyan BTI

Celgene Corporation asserted OTEZLA’s Phase II Clinical Trial data

Arterys sought FDA clearance for Oncology AI suite

Viz.ai sought De Novo FDA clearance for LVO strokes in CTA imaging

DreaMed Diabetics attained CE Mark for Platform tackling Type 1 diabetes

Evofem Biosciences completes enrollment in Phase 3 Clinical Trial for Amphora

Citius enrolls first patient in Mino-Lok Phase 3 Clinical trial

Eisai asserts positive results of Phase 3 Study for lenvatinib mesylate

Merck KGaA and Pfizer assert Phase III JAVELIN Lung 200 trial results

Tusker Medical enlists first patient for OTTER Study